Who
Jon R. Cohen
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Talkspace; SVP OPKO; Exec Chairman BRLI, Opko Health; SVP & Group Exec. Diag. Sol., Quest Diagnostics.
In numbers
- Trades disclosed
- 143
- Buys
- 2
- Sells
- 4
- Bought
- $405K
- Sold
- $30.3M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 10 Feb 2010
- Last trade
- 17 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 17 Aug 2026 | TalkspaceProviders & Facilities | SEC FORM 4 Code D | —1,581,499 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TalkspaceProviders & Facilities | SEC FORM 4 Code D | —1,260,308 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —662,500 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —662,500 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —200,211 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —168,465 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —120,403 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —237,500 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —370,623 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —93,648 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —200,211 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —168,465 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —120,403 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —237,500 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —370,623 | filing |
| 17 Aug 2026filed 17 Aug 2026 | Talkspaceoption or derivative · Providers & Facilities | SEC FORM 4 Code D | —93,648 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TalkspaceProviders & Facilities | SEC FORM 4 Code D | —1,581,499 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TalkspaceProviders & Facilities | SEC FORM 4 Code D | —1,260,308 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TalkspaceProviders & Facilities | SEC FORM 4 Code F | $522K99,720 at $5.23 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TalkspaceProviders & Facilities | SEC FORM 4 Code F | $522K99,720 at $5.23 | filing |
News
Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.13 EPSDGX · themarketsdaily.com · 22 Oct 2026Quest Diagnostics (NYSE: DGX) lifts guidance after revenue jumps 10%DGX · dailypolitical.com · 22 Oct 2026Greenberg Traurig Advises OPKO Health on $722M+ Agreement to Sell Select BioReference Health Assets to LabcorpOPK · prnewswire.com · 21 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthOPK · prnewswire.com · 15 Oct 2026
0 headlines in the last 90 days name Jon R. Cohen; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.